Drug Discovery & Development
McMaster, Sartorius partner on improving biomanufacturing
Sartorius Stedim Biotech and McMaster University, which is located in Hamilton, Ontario, Canada, plan to collaborate on an effort to improve advanced manufacturing processes for antibody and virus-based treatments for diseases like COVID-19 and cancer. Read More
Researchers create 3D tumor models with cells from patients
Using tissue samples from cancer patients, Israeli researchers have successfully printed an active, viable glioblastoma 3D tumor model. In addition to potential applications in personalized medicine, the achievement promises to speed drug development and increase the chances that developed drugs will succeed in clinical trials. The results were published August 18 in Science Advances. Read More
Heat-controlled CAR T cells show improved cancer-killing ability
By adding a genetic on-off switch to engineered CAR T cells, researchers have developed a remote-controlled system that enables precision invasion of the tumor microenvironment for improved cancer-killing capabilities. The details of the research were published in Nature Biomedical Engineering on August 12. Read More
New award program recognizes marketable scientific advances
A new award to recognize researchers who ask fundamental questions at the intersection of life sciences and entrepreneurship has been launched by the American Association for the Advancement of Science and the Copenhagen-based BioInnovation Institute Foundation. Read More
Researchers call for improved reporting of environmental conditions in cell culture
There is an urgent need to improve the reporting of environmental conditions for mammalian cell culture experiments for biomedical research, according to a comment published in Nature Biomedical Engineering on August 13. Read More
Harvard launches Pluto Biosciences collaboration platform
The Harvard Wyss Institute has launched Pluto Biosciences, a new startup offering a cloud-based collaboration platform for researchers that incorporates technology developed within the institute's Predictive Bioanalytics Initiative. Read More
Funding for AI drug development skyrockets in 2021
The market for artificial intelligence (AI) in drug development and clinical trials has seen renewed interest in recent months, with total funding in the industry now reaching $10.7 billion, according to a report published by U.K. market insights firm Signify Research. Read More
PerkinElmer releases new KRAS investigation kits
PerkinElmer has released four new test kits designed to help researchers better understand KRAS protein structures and mutations. The kits will enable cancer researchers to accelerate the identification and optimization of therapeutic leads, the company said. Read More
Antisense oligonucleotide therapies get delivered across the blood-brain barrier
Researchers have demonstrated that heteroduplex oligonucleotide drugs conjugated with cholesterol efficiently cross the blood-brain barrier and can be used to treat central nervous system diseases. The findings were published in Nature Biotechnology on August 12. Read More
Mirus Bio introduces viral vector manufacturing reagents
Mirus Bio announced an expansion of its TransIT VirusGen platform that is compliant with good manufacturing practices viral vector manufacturing to support cell and gene therapy development, process activities, and commercial production. Read More
Conferences
BioTech Pharma Summit
September 27-28
Porto Portugal
Infectious Diseases (ID) Week 2021
September 29 - October 3
San Diego, California United States
Imaging Mass Spectrometry Society (IMSS) 3 in 2021
October 3-6
Colorado Springs, Colorado United States
Cell & Gene Meeting on the Mesa
October 10-14
Carlsbad, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter